Intravenous immunoglobulin regulates anti-desmoglein 3 autoantibody production in B220-antibody-producing cells in mice with pemphigus vulgaris

被引:0
|
作者
Kase, Y. [1 ]
Yamagami, J. [2 ]
Wada, N. [2 ]
Takahashi, H. [2 ]
Koyasu, S. [3 ]
Amagai, M. [2 ]
机构
[1] Japan Blood Prod Org, Cent Res Lab, Kobe, Hyogo, Japan
[2] Keio Univ, Sch Med, Dept Dermatol, Tokyo, Japan
[3] RIKEN, Ctr Integrat Med Sci, Yokohama, Kanagawa, Japan
关键词
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
004
引用
收藏
页码:S1 / S1
页数:1
相关论文
共 23 条
  • [1] Intravenous Ig Regulates Anti-Desmoglein 3 IgG Production in B220e Antibody-Producing Cells in Mice with Pemphigus Vulgaris
    Kase, Yuko
    Takahashi, Hayato
    Ito, Hiromi
    Kamata, Aki
    Amagai, Masayuki
    Yamagami, Jun
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2022, 142 (07) : 1786 - +
  • [2] Influence of intravenous immunoglobulin therapy on autoantibody titers to desmoglein 3 and desmoglein 1 in pemphigus vulgaris
    Sami, N
    Bhol, KC
    Ahmed, RA
    [J]. EUROPEAN JOURNAL OF DERMATOLOGY, 2003, 13 (04) : 377 - 381
  • [3] Anti-Desmoglein 1 and 3 Autoantibody Levels in Endemic Pemphigus Foliaceus and Pemphigus Vulgaris from Brazil
    Oliveira, Liana A.
    Marquart-Filho, Alfredo
    Trevilato, Gerson
    Timoteo, Rodolfo P.
    Mukai, Maira
    Roselino, Ana M. F.
    Petzl-Erler, Maria L.
    [J]. CLINICAL LABORATORY, 2016, 62 (07) : 1209 - 1216
  • [4] Standardized Production of Anti-Desmoglein 3 Antibody AK23 for Translational Pemphigus Vulgaris Research
    Mueller, Eliane J.
    Rahimi, Siavash
    Sauta, Patrizia
    Shojaeian, Taravat
    Durrer, Laurence
    Quinche, Soraya
    Francois, Michael
    Locher, Elisabeth
    Edler, Monika
    Illi, Marlies
    Gentinetta, Thomas
    Lau, Kelvin
    Pojer, Florence
    Borradori, Luca
    Hariton, William V. J.
    [J]. CURRENT PROTOCOLS, 2024, 4 (08):
  • [5] Correlation between salivary and serum anti-desmoglein 1 and 3 antibody titres using ELISA and between anti-desmoglein levels and disease severity in pemphigus vulgaris
    De, D.
    Khullar, G.
    Handa, S.
    Joshi, N.
    Saikia, B.
    Minz, R. W.
    [J]. CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2017, 42 (06) : 648 - 650
  • [6] Dichotomy of anti-desmoglein 1 and -3 autoantibody profiles in pemphigus vulgaris (PV) patients carrying distinct HLA alleles
    Talsma, J.
    Stepanovich, M.
    Chow, S.
    Seiffert, K.
    Sinha, A. A.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2007, 127 : S16 - S16
  • [7] Efficacy of intravenous immunoglobulin (IVIG) affinity-purified anti-desmoglein anti-idiotypic antibodies in the treatment of an experimental model of pemphigus vulgaris
    Mimouni, D.
    Blank, M.
    Payne, A. S.
    Anhalt, G. J.
    Avivi, C.
    Barshack, I.
    David, M.
    Shoenfeld, Y.
    [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2010, 162 (03): : 543 - 549
  • [8] FcγRIIb deficiency accelerates immunoglobulin class switch and pemphigus phenotype development in pathogenic anti-desmoglein 3 antibody knock-in mice
    Nomura, H.
    Takahashi, H.
    Kase, Y.
    Yamagami, J.
    Wada, N.
    Koyasu, S.
    Amagai, M.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2018, 138 (05) : S3 - S3
  • [9] Generation of an anti-desmoglein 3 antibody without pathogenic activity of pemphigus vulgaris for therapeutic application to squamous cell carcinoma
    Funahashi, Shin-Ichi
    Kawai, Shigeto
    Fujii, Etsuko
    Taniguchi, Kenji
    Nakano, Kiyotaka
    Ishikawa, Shumpei
    Aburatani, Hiroyuki
    Suzuki, Masami
    [J]. JOURNAL OF BIOCHEMISTRY, 2018, 164 (06): : 471 - 481
  • [10] Acantholysis may precede elevation of circulating anti-desmoglein 3 antibody levels in pemphigus vulgaris presenting with desquamative gingivitis
    Endo, Hiroyasu
    Rees, Terry D.
    Niwa, Hideo
    Kuyama, Kayo
    Oshima, Maya
    Serizawa, Tae
    Tanaka, Shigeo
    Komiya, Masamichi
    Ito, Takanori
    [J]. CLINICAL AND EXPERIMENTAL DENTAL RESEARCH, 2019, 5 (03): : 219 - 224